GKOS Chart
- 52-Week Range: $34.86 - $86.37
- Market Capitalization: $1.86B
- Short Percentage: 0%
- Target Price: $56.43
- Shares Outstanding: 47.33M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
GKOS released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Glaukos Announces Participation in the Piper Sandler Virtual Ophthalmology SymposiumBusiness Wire | May 20th
- Glaukos Corporation (GKOS) CEO Tom Burns on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha | May 4th
- Glaukos to Release First Quarter 2022 Financial Results after Market Close on May 4Business Wire | April 13th
- Glaukos Corporation (GKOS) CEO Tom Burns on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 23rd
- Glaukos Corporation Announces Fourth Quarter and Full Year 2021 Financial ResultsBusiness Wire | February 22nd
- Glaukos' iDose TR Shows Sustained Reduction In Ocular Pressure, Favorable Safety ProfileBenzinga | January 12th
- Glaukos Announces First Patient Enrolled in Phase 2 Clinical Trial for Dry Eye DiseaseBusiness Wire | January 11th
- Glaukos Announces First Patient Enrolled in Phase 2 Clinical Trial for PresbyopiaBusiness Wire | January 11th
- Glaukos Announces Participation in the J.P. Morgan Healthcare ConferenceBusiness Wire | December 29th
Company Info
Website: https://www.glaukos.com
Address: 229 Avenida Fabricante, San Clemente, CA, United States, 92672
Sector: Healthcare
Industry: Medical Instruments & Supplies
Full time employees: 727
Address: 229 Avenida Fabricante, San Clemente, CA, United States, 92672
Sector: Healthcare
Industry: Medical Instruments & Supplies
Full time employees: 727
$GKOS ADDING MORE…
$GKOS wtf is that dump
$GKOS buy the fear
$GKOS Slapping that ask today
$GKOS let’s go baby!
$GKOS Up! Up! Up! Up! Up! Up! Up!
$GKOS Bears crying right now